EE200300379A - Alkylphenyliminoimidazolidine derivatives for the treatment of urinary incontinence - Google Patents

Alkylphenyliminoimidazolidine derivatives for the treatment of urinary incontinence

Info

Publication number
EE200300379A
EE200300379A EEP200300379A EEP200300379A EE200300379A EE 200300379 A EE200300379 A EE 200300379A EE P200300379 A EEP200300379 A EE P200300379A EE P200300379 A EEP200300379 A EE P200300379A EE 200300379 A EE200300379 A EE 200300379A
Authority
EE
Estonia
Prior art keywords
alkylphenyliminoimidazolidine
derivatives
treatment
urinary incontinence
incontinence
Prior art date
Application number
EEP200300379A
Other languages
Estonian (et)
Inventor
Esser Franz
Pouzet Pascale
Kitagawa Hisato
Sakai Kenji
Muramatsu Ikunobu
Hoffmann Matthias
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300379A publication Critical patent/EE200300379A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200300379A 2001-02-10 2002-01-22 Alkylphenyliminoimidazolidine derivatives for the treatment of urinary incontinence EE200300379A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (en) 2001-02-10 2001-02-10 New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence
PCT/EP2002/000576 WO2002064570A1 (en) 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence

Publications (1)

Publication Number Publication Date
EE200300379A true EE200300379A (en) 2003-12-15

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300379A EE200300379A (en) 2001-02-10 2002-01-22 Alkylphenyliminoimidazolidine derivatives for the treatment of urinary incontinence

Country Status (21)

Country Link
EP (1) EP1362038A1 (en)
JP (1) JP2004517963A (en)
KR (1) KR20030076653A (en)
CN (1) CN1491216A (en)
AR (1) AR035226A1 (en)
BG (1) BG108036A (en)
BR (1) BR0206949A (en)
CA (1) CA2437809A1 (en)
CZ (1) CZ20032146A3 (en)
DE (1) DE10106214A1 (en)
EA (1) EA200300835A1 (en)
EC (1) ECSP034700A (en)
EE (1) EE200300379A (en)
HU (1) HUP0303004A3 (en)
IL (1) IL157297A0 (en)
MX (1) MXPA03007127A (en)
NO (1) NO20033368L (en)
PL (1) PL362149A1 (en)
SK (1) SK10132003A3 (en)
WO (1) WO2002064570A1 (en)
ZA (1) ZA200305609B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4454622B2 (en) * 2003-05-09 2010-04-21 エフ.ホフマン−ラ ロシュ アーゲー Methylindole and methylpyrrolopyridine as alpha-1 adrenergic agonists
JP4168086B1 (en) * 2008-04-16 2008-10-22 国立大学法人福井大学 Imidazoline derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence
FR2761061B1 (en) * 1997-03-20 1999-04-23 Synthelabo BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
IL157297A0 (en) 2004-02-19
JP2004517963A (en) 2004-06-17
MXPA03007127A (en) 2003-11-18
CN1491216A (en) 2004-04-21
NO20033368D0 (en) 2003-07-28
KR20030076653A (en) 2003-09-26
AR035226A1 (en) 2004-05-05
DE10106214A1 (en) 2002-08-14
PL362149A1 (en) 2004-10-18
HUP0303004A2 (en) 2003-12-29
ZA200305609B (en) 2004-04-29
ECSP034700A (en) 2003-08-29
BG108036A (en) 2004-12-30
HUP0303004A3 (en) 2004-07-28
CZ20032146A3 (en) 2003-12-17
SK10132003A3 (en) 2004-02-03
NO20033368L (en) 2003-07-28
BR0206949A (en) 2004-02-25
EA200300835A1 (en) 2004-02-26
CA2437809A1 (en) 2002-08-22
EP1362038A1 (en) 2003-11-19
WO2002064570A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
NO20035156L (en) Well Treatment Procedures
DE60205514D1 (en) disposable diaper
NO20041833L (en) Heterocyclic compounds for use in the treatment of urinary tract disorders
EE200300396A (en) Use of epothilone derivatives for the treatment of refractory tumors
EE200300397A (en) Epothilone derivatives for the treatment of refractory tumors
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
PL369062A1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
DK1516596T3 (en) Improved system for the treatment of stress urinary incontinence
NO20030978L (en) Treatment of urinary dysfunction
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA
NO20012569D0 (en) Use of aryl-substituted cyclobutylamines for the treatment of urinary incontinence
EE200300379A (en) Alkylphenyliminoimidazolidine derivatives for the treatment of urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
EE200300177A (en) m-aminophenyliminoimidazolidine derivatives for the treatment of urinary incontinence
NO20033428L (en) Use of 2-amino-1 (4-hydroxy-3-methanesulfonamidophenyl) ethanol for the treatment of urinary incontinence
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
SI1413305T1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
AU2002317183B2 (en) ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
AU2002317183A1 (en) ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
FI20011540A0 (en) Disposable urinary incontinence cap for men
ZA200309473B (en) Arylazo-substituted imidazole for the treatment of stress urinary incontinence.
ITMI20011705A0 (en) NON-ASTEROID ANTI-INFLAMMATORY FOR THE RECTAL TREATMENT OF DIOLIGASTENOSPERMIA